Evidence map›Paper›PMID 38969942›Full record

ReviewRheumatology international2024

Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion.

Ana Urruticoechea-Arana, José Luis Álvarez-Vega, Maria Luz García-Vivar, José Antonio Pinto-Tasende, María Jesús García de Yébenes, Loreto Carmona, Rubén Queiro

Abstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Urruticoechea-AranaRheumatology, Hospital Universitario Son Espases, Carretera de Valldemossa, 79, Palma, Illes Balears, Nord, 07120, Spain. anboliv@yahoo.es.ORCID 0000-0001-8290-1846
José Luis Álvarez-VegaRheumatology, Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain.
Maria Luz García-VivarRheumatology, Hospital Universitario de Basurto, Bilbao, Spain.ORCID 0000-0001-8822-9843
José Antonio Pinto-TasendeRheumatology, Complejo Hospitalario Universitario de A Coruña, La Coruña, Spain.ORCID 0000-0002-4993-8185
María Jesús García de YébenesInstituto de Salud Musculoesquelética (Inmusc), Madrid, Spain.ORCID 0000-0003-0358-6070
Loreto CarmonaInstituto de Salud Musculoesquelética (Inmusc), Madrid, Spain.ORCID 0000-0002-4401-2551
Rubén QueiroRheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID 0000-0002-8418-7145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence-based treatment recommendations for psoriatic arthritis (PsA) suggest that treatment should be individualised but acknowledge the difficulty of correctly defining levels of activity (mild, moderate and severe). The aim of this study was to define the parameters or disease characteristics that should be included in a future definition of moderate PsA. Mixed. methods: (1) literature review to identify previous assessment tools used to classify patients into mild, moderate and severe forms, and (2) survey of rheumatologists, and experts in PsA, to obtain their opinion on the degree of validation and applicability of published definitions and tools, and on the parameters that should be included in a future definition of moderate PsA. We propose eight domains/items to be included in a definition of moderate PsA: number of active joints and inflamed entheses, physician global assessment (by visual analogue scale), dactylitis, body surface area (BSA) affected by psoriasis, psoriasis in special locations, and absence of hip involvement. The Disease Activity Index for Psoriatic Arthritis (DAPSA) score would be supported as part of this definition, as would the Psoriatic Arthritis Impact of Disease (PsAID) index. This study proposes a set of items/domains to be included in a definition of moderate PsA based on literature and expert opinion, which can be the starting point for further development and validation studies of the proposed items.

Indexed as

Arthritis, PsoriaticSeverity of Illness IndexHumansRheumatologyDefinitionModeratePsoriatic arthritisReviewSurvey

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.